The latest medical research on Neuroendocrine Tumors

The research magnet gathers the latest research from around the web, based on your specialty area. Below you will find a sample of some of the most recent articles from reputable medical journals about neuroendocrine tumors gathered by our medical AI research bot.

The selection below is filtered by medical specialty. Registered users get access to the Plexa Intelligent Filtering System that personalises your dashboard to display only content that is relevant to you.

Want more personalised results?

Request Access

Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patients.

Neuroendocrine Tumors

Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with a poor prognosis. Mitotane, a derivative of the pesticide DDT, has been used suc...

Long-term survival of metastatic small intestine neuroendocrine tumors: a meta-analysis.

Neuroendocrine Tumors

This meta-analysis aims to evaluate long-term survival and prognostic factors in patients with metastatic small intestine neuroendocrine tumors (si...

The role of vitamin D in breast cancer risk and progression.

Neuroendocrine Tumors

The active form of vitamin D3, 1,25-dihydroxvitamin D3 [1,25(OH)2D3], is primarily known as a key regulator of calcium and phosphate homeostasis. I...

β-catenin activation and illicit receptor expression in adrenocortical cells.

Neuroendocrine Tumors

Adrenal cortisol-producing tumors can express illicit membrane receptors such as luteinizing hormone (LH), glucose-dependent insulinotropic peptide...

Cancer-associated adipocytes release FUCA2 to promote aggressiveness in TNBC.

Neuroendocrine Tumors

Cancer-associated adipocytes (CAAs) have been suggested to promote tumor progression. Yet, the role of CAAs in triple-negative breast cancer (TNBC)...

Pregnancy-associated breast cancer: the influence of gestational age.

Neuroendocrine Tumors

Whether PABC tumors arise before or during pregnancy and whether histopathology is affected by gestational age is currently unclear. The present st...

Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trial.

Neuroendocrine Tumors

Molecular mechanisms linking obesity to prostate cancer involve steroid hormone and insulin/insulin-like growth factor-1 (IGF-1) pathways. We inves...

Reduced MHC class II expression in medullary thyroid cancer identifies patients with poor prognosis.

Neuroendocrine Tumors

Increasing body of recent studies determining the expression of tumor-specific major histocompatibility complex (MHC) class II protein support its ...

TREM1 fosters an immunosuppressive tumor microenvironment in papillary thyroid cancer.

Neuroendocrine Tumors

The immunosuppressive microenvironment is associated with poor prognosis in papillary thyroid cancer (PTC); however, the molecular mechanisms invol...

ACT001 reverses resistance of prolactinomas via AMPK-mediated EGR1 and mTOR pathway.

Neuroendocrine Tumors

Dopamine agonist (DA) is the first choice for the treatment of prolactinomas and drug resistance is unavoidable during treatment due to the heterog...

SREBP1 promotes invasive phenotypes by upregulating CYR61/CTGF via the Hippo-YAP pathway.

Neuroendocrine Tumors

Aberrant lipid metabolism provides bioenergetic, biosynthetic, and redox supplies to cancer cells. Previous studies have reported differential lipi...

Aldosterone-producing nodules and CYP11B1 signaling correlate in primary aldosteronism.

Neuroendocrine Tumors

Autonomous cortisol secretion (ACS) could be found in some patients with unilateral primary aldosteronism (uPA). However, the histopathological pat...